GENinCode (LON:GENI – Get Free Report) issued its quarterly earnings results on Tuesday. The company reported GBX (0.38) EPS for the quarter, Digital Look Earnings reports. GENinCode had a negative return on equity of 481.34% and a negative net margin of 202.42%.
GENinCode Price Performance
GENI traded up GBX 0.04 during trading on Thursday, reaching GBX 0.73. The stock had a trading volume of 2,103,826 shares, compared to its average volume of 5,110,390. The business has a 50-day moving average of GBX 0.88 and a 200-day moving average of GBX 0.98. GENinCode has a one year low of GBX 0.64 and a one year high of GBX 4.90. The company has a debt-to-equity ratio of 4.75, a quick ratio of 15.88 and a current ratio of 2.22. The stock has a market cap of £5.53 million, a PE ratio of -0.35 and a beta of 0.59.
About GENinCode
GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.
GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset.
Featured Stories
- Five stocks we like better than GENinCode
- Everyone in AI Is Quietly Copying Palantir’s Playbook
- Advanced Micro Devices Is Spending $8.2 Billion to Learn What AI Needs Next
- JPMorgan Bets on Genius Sports as the Market Loses Patience
- Apple’s $5.7 Billion Patent Verdict Raises a Bigger Royalty Question
Receive News & Ratings for GENinCode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENinCode and related companies with MarketBeat.com's FREE daily email newsletter.
